Finance

Beta
Lists
4588:TYO
Oncolys Biopharma Inc
¥2,519.00
+0.24%
(+6.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4588...
Open
¥2,483
High
¥2,555
Low
¥2,343
Mkt. cap
73.82B
Avg. vol.
1.63M
Volume
1.44M
52-wk high
¥3,695
52-wk low
¥570
EPS
-¥62
Shares outstanding
13.14M
No. of employees
44
Open
¥2,483
High
¥2,555
Low
¥2,343
Mkt. cap
73.82B
Avg. vol.
1.63M
Volume
1.44M
52-wk high
¥3,695
52-wk low
¥570
EPS
-¥62
Shares outstanding
13.14M
No. of employees
44
News stories
From sources across the web
About Oncolys Biopharma Inc
CEO-
Employees44
FoundedMar 18, 2004
Headquarters-
SectorBiotechnology
Websiteoncolys.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Revenue
-
28.55M
-
3.09M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
785.20M
510.47M
303.94M
423.81M
Operating expense
789.24M
511.47M
305.01M
423.81M
Total operating expenses
789.24M
511.47M
305.01M
423.81M
Operating income
-789.24M
-482.92M
-305.01M
-420.72M
Other non operating income
13.00K
13.00K
-8.69M
-2.14M
EBT including unusual items
-810.79M
-500.86M
-302.92M
-413.36M
EBT excluding unusual items
-810.79M
-500.86M
-302.92M
-413.36M
Income tax expense
863.00K
713.00K
891.00K
1.12M
Effective tax rate
-0.11%
-0.14%
-0.29%
-0.27%
Other operating expenses
-
-
-
-
Net income
-811.65M
-501.58M
-303.81M
-414.48M
Net profit margin
-
-1,757.08%
-
-13,413.66%
Earnings per share
-
-
-
-
Interest and investment income
1.35M
479.00K
1.52M
3.04M
Interest expense
-1.08M
-1.20M
-1.51M
-2.99M
Net interest expenses
263.00K
-725.00K
10.00K
58.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-789.03M
-482.90M
-304.80M
-420.71M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer